These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 16530300

  • 1. Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season.
    Kamada M, Nagai T, Kumagai T, Igarashi M, Ihara T, Okafuji T, Ochiai H, Sakiyama H, Shimomura K, Suzuki E, Torigoe S, Miyazaki C, Miyata A, Yuri K, Ito Y, Nakayama T, Kase T, Okuno Y.
    Vaccine; 2006 Apr 24; 24(17):3618-23. PubMed ID: 16530300
    [Abstract] [Full Text] [Related]

  • 2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 24; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 24; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 4. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y.
    J Infect Dis; 2009 Jan 15; 199(2):168-79. PubMed ID: 19086914
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK, Marshfield Influenza Study Group.
    J Infect Dis; 2009 Jan 15; 199(2):159-67. PubMed ID: 19086915
    [Abstract] [Full Text] [Related]

  • 6. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD, CAIV-T Study Group.
    Pediatr Infect Dis J; 2006 Oct 15; 25(10):870-9. PubMed ID: 17006279
    [Abstract] [Full Text] [Related]

  • 7. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Apr 18; 57(15):393-8. PubMed ID: 18418344
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.
    Beran J, Vesikari T, Wertzova V, Karvonen A, Honegr K, Lindblad N, Van Belle P, Peeters M, Innis BL, Devaster JM.
    J Infect Dis; 2009 Dec 15; 200(12):1861-9. PubMed ID: 19909082
    [Abstract] [Full Text] [Related]

  • 9. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G.
    Vaccine; 2007 Apr 12; 25(15):2842-51. PubMed ID: 17081662
    [Abstract] [Full Text] [Related]

  • 10. Duration of protection provided by live attenuated influenza vaccine in children.
    Ambrose CS, Yi T, Walker RE, Connor EM.
    Pediatr Infect Dis J; 2008 Aug 12; 27(8):744-8. PubMed ID: 18600188
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J.
    Vaccine; 2009 Feb 11; 27(7):1101-10. PubMed ID: 19095024
    [Abstract] [Full Text] [Related]

  • 12. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730
    [Abstract] [Full Text] [Related]

  • 13. Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia.
    Blair PJ, Wierzba TF, Touch S, Vonthanak S, Xu X, Garten RJ, Okomo-Adhiambo MA, Klimov AI, Kasper MR, Putnam SD.
    Epidemiol Infect; 2010 Feb 17; 138(2):199-209. PubMed ID: 19698213
    [Abstract] [Full Text] [Related]

  • 14. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.
    Pediatrics; 2007 Sep 17; 120(3):e553-64. PubMed ID: 17698577
    [Abstract] [Full Text] [Related]

  • 15. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM, Yi T, Ambrose CS.
    Vaccine; 2011 Jun 10; 29(26):4322-7. PubMed ID: 21513761
    [Abstract] [Full Text] [Related]

  • 16. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP.
    Pediatr Infect Dis J; 2008 Oct 10; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [Abstract] [Full Text] [Related]

  • 17. Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season.
    Fujieda M, Maeda A, Kondo K, Kaji M, Hirota Y.
    Vaccine; 2006 Feb 13; 24(7):957-63. PubMed ID: 16171903
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy.
    Shahgholi E, Ehsani MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T.
    Pediatr Blood Cancer; 2010 May 13; 54(5):716-20. PubMed ID: 20205258
    [Abstract] [Full Text] [Related]

  • 19. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 May 22; 58(19):521-4. PubMed ID: 19478718
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC.
    N Engl J Med; 2009 Sep 24; 361(13):1260-7. PubMed ID: 19776407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.